v3.26.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
12 Months Ended
Jan. 31, 2026
Equity [Abstract]  
Schedule of Temporary Equity
The following tables summarize the Company’s outstanding redeemable convertible preferred stock (collectively, the “Preferred Stock”, as of January 31, 2025 and prior to the completion of the Company’s IPO, (in thousands, except price per share amounts and share data):
As of January 31, 2025
Shares
Authorized
Shares Issued and OutstandingOriginal Issuance Price Per ShareLiquidation
Amount
Carrying Value
Series Seed16,934,856 16,934,839 $0.25 $4,181 $4,729 
Series A20,382,688 20,382,673 $0.50 10,125 10,288 
Series A-121,353,147 21,353,143 $0.59 12,500 12,670 
Series B27,505,170 27,465,006 $1.87 51,225 51,153 
Series C21,158,278 19,770,427 $7.21 142,454 142,398 
Series C-11,387,848 1,387,848 $7.21 10,000 9,996 
Series D12,592,724 12,592,720 $22.23 279,917 279,676 
Series E13,859,852 13,859,845 $26.12 362,000 361,700 
Series F8,501,429 8,501,424 $32.35 275,000 274,827 
Series G8,010,956 2,670,319 $37.45 100,000 99,794 
Series G-15,340,637 1,441,963 $37.45 54,000 53,890 
157,027,585 146,360,207 $1,301,402 $1,301,121 
Schedule of Capital Units
Common stock reserved for issuance as of January 31, 2026 and 2025 are summarized as follows:
As of January 31,
20262025
Redeemable convertible preferred stock— 146,360,207 
Stock options issued and outstanding39,283,485 40,971,097 
RSUs issued and outstanding9,311,201 4,653,847 
Shares of common stock available for future grants37,811,841 5,486,445 
Redeemable convertible preferred stock warrants— 40,160 
Total common stock reserved for issuance86,406,527 197,511,756